- For Patients
- Introduction to the Marshall Protocol
- Length of the MP
- Immunopathology
- Managing immunopathology
- Food and drink
- Light restriction
- Vitamin D metabolite calculator - get feedback on vitamin D results
- Therapeutic probe - best method for determining MP suitability
- Starting the Marshall Protocol
- Resources for patients
- Marshall Protocol summary
- Palliative vs. curative treatments
- Patient interviews on Bacteriality
- Non-MP treatments
- Glossary
- The Protocol
- Marshall Protocol summary
- Publications and presentations
- Science behind immunopathology
- Science behind olmesartan (Benicar)
- Safety of olmesartan
- Resources for physicians
- Vitamin D metabolite calculator - get feedback on vitamin D results
- Therapeutic probe - best method for determining MP suitability
- Physicians' concerns about the MP
- Notice for emergency medical personnel
- The Pathogenesis
- Publications and presentations
- Science behind Marshall Pathogenesis
- Microbes in the human body
- Successive infection and variability in disease
- Autoimmune theory of disease
- Science behind vitamin D
- Metabolism of vitamin D and the VDR
- Th1 Spectrum Disorder - how chronic inflammatory diseases are related
- Transmission of bacteria and onset of chronic disease
- Evolutionary perspective on disease
- Incidence and prevalence of disease
- Evidence that chronic disease is caused by pathogens
- Diseases
- Foundation
- Related Sites
Media Manager
Namespaces
Choose namespace
Media Files
Files in home:medications
- 200mg_qod.gif
- 525×280
- 10.24.2009
- 19.1 KB
- ace.gif
- 520×307
- 10.24.2009
- 26.4 KB
- australia.png
- 24×24
- 10.24.2009
- 1.1 KB
- camels.jpg
- 250×157
- 10.24.2009
- 19.2 KB
- canada.png
- 24×24
- 10.24.2009
- 843 B
- canada24.png
- 24×24
- 10.24.2009
- 843 B
- confused.gif
- 15×15
- 10.24.2009
- 605 B
- cool.gif
- 15×15
- 10.24.2009
- 597 B
- european_union.png
- 24×24
- 10.24.2009
- 909 B
- five.gif
- 50×50
- 10.24.2009
- 1.7 KB
- four.gif
- 50×50
- 10.24.2009
- 1.6 KB
- germany.png
- 24×24
- 10.24.2009
- 483 B
- mad.gif
- 15×15
- 10.24.2009
- 154 B
- new_zealand.png
- 24×24
- 10.24.2009
- 968 B
- olmecip.jpg
- 175×214
- 10.24.2009
- 29.8 KB
- one.gif
- 50×50
- 10.24.2009
- 1.1 KB
- p03332c1.jpg
- 300×326
- 10.24.2009
- 13.8 KB
- p05337d2.jpg
- 300×374
- 10.24.2009
- 24.1 KB
- psp300.jpg
- 500×500
- 10.24.2009
- 167 KB
- sad.gif
- 15×15
- 10.24.2009
- 281 B
- seven.gif
- 50×50
- 10.24.2009
- 1.6 KB
- shock.gif
- 15×15
- 10.24.2009
- 361 B
- six.gif
- 50×50
- 10.24.2009
- 1.7 KB
- smile.gif
- 15×15
- 10.24.2009
- 277 B
- spain.png
- 24×24
- 10.24.2009
- 666 B
- three.gif
- 50×50
- 10.24.2009
- 1.7 KB
- two.gif
- 50×50
- 10.24.2009
- 1.6 KB
- united_nations.png
- 24×24
- 10.24.2009
- 921 B
- united_states_of_america.png
- 24×24
- 10.24.2009
- 656 B
![[root]](/home?ns=&tab_files=files&do=media&tab_details=view&image=home%3Amedications%3Aace.gif){kind=link}
File
- View
- History
- Date:
- 10.24.2009
- Filename:
- ace.gif
- Format:
- GIF
- Size:
- 26KB
- Width:
- 520
- Height:
- 307
- References for:
- Immunopathology
- Test: Angiotensin-Converting Enzyme (ACE)
home.txt · Last modified: 03.12.2023 by 127.0.0.1
© 2015, Autoimmunity Research Foundation. All Rights Reserved.